Virtual Clinical Trials Market, By Study Type (Interventional and Others), By Phases (Late Stage and Early Stage), By Company Size (Small- & Mid-sized and Large-sized), By Therapeutic Area (Oncology, Rare & Genetic Diseases, CNS, Immunology, and Others),

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,500	161 Pages	Coherent Market Insights	April, 2023	CMI17913848

Best Price Guarantee
Price	from $4,500
Length	161 Pages
Publisher	Coherent Market Insights
Published Date	April, 2023
SKU	CMI17913848

Virtual Clinical Trials Market, By Study Type (Interventional and Others), By Phases (Late Stage and Early Stage), By Company Size (Small- & Mid-sized and Large-sized), By Therapeutic Area (Oncology, Rare & Genetic Diseases, CNS, Immunology, and Others), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

Virtual clinical trials is a relatively new method of conducting clinical research using technologies and online social engagement platforms. Virtual trials have the potential to drive significant digital alterations in the clinical research methodologies to create an improved patient-centric ecosystem. Virtual clinical trials are digitally empowered the clinical trial process.

Market Dynamics:

Growing burden of diseases, spike in virtual clinical trials adoption, rise in adoption of telehealth, rise in adoption of novel technologies, rise in healthcare digitization, technological advancements, and the outbreak of COVID-19 (pandemic) are major factors expected to boost the growth of the global virtual clinical trials market during the forecast period.

For instance, in November 2019, Johnson & Johnson in collaboration with PRA Health Sciences, launched the clinical trial set-up CHIEF-HF, a completely decentralize, indication-seeking, mobile clinical study. The company aims to utilize wearable devices and smart technology to efficiently gather and analyze evidence for assessing effectiveness of Canagliflozin in the populace with heart failure with presence of absence of type 2 diabetes.

Key features of the study:

This report provides in-depth analysis of the global virtual clinical trials market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2023–2030), considering 2022 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global virtual clinical trials market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Delve Health, Clario, Clinical Ink, Castor, Accenture, Thread, Science 37, Medable, Dassault Systèmes, and eElinicalHealth (CLINPAL), among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global virtual clinical trials market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global virtual clinical trials market.

Detailed Segmentation:

Global Virtual Clinical Trials Market, By Study Type:
Interventional
Others
Global Virtual Clinical Trials Market, By Phases:
Late Stage
Early Stage
Global Virtual Clinical Trials Market, By Company Size:
Small- & Mid-sized
Large-sized
Global Virtual Clinical Trials Market, By Therapeutic Area:
Oncology
Rare & Genetic Diseases
CNS
Immunology
Others
Global Virtual Clinical Trials Market, By Geography:
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
Company Profiles:
Delve Health
Clario
Clinical Ink
Castor
Accenture
Thread
Science 37
Medable
Dassault Systèmes
eElinicalHealth (CLINPAL)

1. Research Objectives and Assumptions: Research Objectives; Assumptions; Abbreviations
2. Market Purview: Report Description; Market Definition and Scope; Executive Summary; Market Snapshot, By Study Type; Market Snapshot, By Phases; Market Snapshot, By Company Size; Market Snapshot, By Therapeutic Area; Market Snapshot, By Geography; Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis: Market Dynamics; Increase in number of virtual clinical trials worldwide; Challenges associated with virtual clinical trials; Growing burden of diseases and outbreak of COVID-19; Impact Analysis; Key Highlights; Regulatory Scenario; Product launch/Approvals; PEST Analysis; PORTER’s Analysis; Merger and Acquisition Scenario
4. Global Virtual Clinical Trials Market – Impact of Coronavirus (COVID-19) Pandemic: COVID-19 Epidemiology; Supply Side and Demand Side Analysis; Economic Impact
5. Global Virtual Clinical Trials Market, By Study Type, 2017-2030, (US$ Mn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2017 - 2030; Segment Trends; Interventional; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn); Others; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
6. Global Virtual Clinical Trials Market, By Phases, 2017-2030, (US$ Mn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2017 - 2030; Segment Trends; Late Stage; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn); Early Stage; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
7. Global Virtual Clinical Trials Market, By Company Size, 2017-2030, (US$ Mn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2017 - 2030; Segment Trends; Small- & Mid-sized; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn); Large-sized; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
8. Global Virtual Clinical Trials Market, By Therapeutic Area, 2017-2030, (US$ Mn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2017 - 2030; Segment Trends; Oncology; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn); Rare & Genetic Diseases; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn); CNS; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn); Immunology; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn); Others; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
9. Global Virtual Clinical Trials Market, By Geography, 2017-2030, (US$ Mn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2017 - 2030; Segment Trends; North America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Study Type, 2017-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Phases, 2017-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Company Size, 2017-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2017-2030,(US$ Mn); Europe; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Study Type, 2017-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Phases, 2017-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Company Size, 2017-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2017-2030,(US$ Mn); Asia Pacific; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Study Type, 2017-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Phases, 2017-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Company Size, 2017-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2017-2030,(US$ Mn); Latin America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Study Type, 2017-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Phases, 2017-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Company Size, 2017-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2017-2030,(US$ Mn); Middle East & Africa; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Study Type, 2017-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Phases, 2017-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Company Size, 2017-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2017-2030,(US$ Mn); 10. Competitive Landscape; Delve Health; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Clario; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Clinical Ink; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Castor; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Accenture; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Thread; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Science 37; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Medable; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Dassault Systèmes; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; eElinicalHealth (CLINPAL); Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Analyst Views; 11. Section; Research Methodology; About us; *Browse 24 market data tables and 28 figures on "Global Virtual Clinical Trials Market” - forecast to 2030

Macular Degeneration Treatment Market Report by Type (Dry Age-related Macular Degeneration, Wet Age-related Macular Degeneration), Stage of Disease (Early Stage, Intermediate Stage, Late Stage), Route of Administration (Intravenous Route, Intravitreal Route), End User (Hospitals, Ambulatory Surgical Center, and Others), and Region 2024-2032

April, 2024 | Published by: IMARC Services Pvt. Ltd. | USD $3,899
Precision Diagnostics Market, By Product (Kits & Assays and Consumables), By Technology (Next-Generation Sequencing, Polymerase Chain Reaction, Mass Spectrometry, and Others), By Application (Accurate Diagnosis, Personalized Treatment, Early Detection and Intervention, and Others), By Indication (Oncology, Cardiovascular, Immunology, Neurology, Infectious Diseases, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

March, 2024 | Published by: Coherent Market Insights | USD $4,500
North America Precision Diagnostics Market Size, Share & Trends Analysis Report By End-use, By Type, By Application (Oncology, Respiratory Diseases, CNS Disorders, Immunology, Skin Diseases, Genetic Diseases, and Others), By Country and Growth Forecast, 2024 - 2031

July, 2024 | Published by: Knowledge Based Value (KBV) Research | USD $1,500
Global Macular Degeneration Treatment Market Size Study, by Type (Dry Age-related Macular Degeneration, Wet Age-related Macular Degeneration), by Stage of Disease (Early-stage AMD, Intermediate AMD, Late-stage AMD), by Treatment Type (Drug, Devices, Surgery), by Sales Channel (Ambulatory Surgical Centers, Hospitals, Others) and Regional Forecasts 2022-2032

August, 2024 | Published by: Bizwit Research & Consulting | USD $4,950
Macular Degeneration Treatment Market, By Type (Dry Age-related Macular Degeneration and Wet Age-related Macular Degeneration), By Stage Of Disease (Early-stage AMD, Intermediate AMD, and Late-stage AMD), By Route Of Administration (Intravenous Route and Intravitreal Route), By Sales Channel (Ambulatory Surgical Centres, Hospitals, and Other Sales Channels), and By Geography (North America Europe, Asia-Pacific, South America, and Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

August, 2022 | Published by: Coherent Market Insights | USD $4,500
Global Precision Medicine Market Size study & Forecast, by Technology ( Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics and Other Technologies) by Application ( Oncology, CNS, Immunology, Respiratory and Other Applications), and Regional Analysis, 2022-2029

May, 2023 | Published by: Bizwit Research & Consulting | USD $4,950

PDF E-mail From Publisher:	$4,500
Site License Fulfilled by Publisher:	$7,000
Global Site License Fulfilled by Publisher:	$10,000

Virtual Clinical Trials Market, By Study Type (Interventional and Others), By Phases (Late Stage and Early Stage), By Company Size (Small- & Mid-sized and Large-sized), By Therapeutic Area (Oncology, Rare & Genetic Diseases, CNS, Immunology, and Others),

Research Assistance

Other tasks

Virtual Clinical Trials Market, By Study Type (Interventional and Others), By Phases (Late Stage and Early Stage), By Company Size (Small- & Mid-sized and Large-sized), By Therapeutic Area (Oncology, Rare & Genetic Diseases, CNS, Immunology, and Others),

North America Precision Diagnostics Market Size, Share & Trends Analysis Report By End-use, By Type, By Application (Oncology, Respiratory Diseases, CNS Disorders, Immunology, Skin Diseases, Genetic Diseases, and Others), By Country and Growth Forecast, 2024 - 2031

Research Assistance

Other tasks